NCT06358898

Brief Summary

Emerging encouraging evidence showed that sleep focused treatment can simultaneously improve sleep and depression in adult with comorbid conditions. Although these favorable changes in depressed adults is encouraging, little is known in the potential efficacy of CBT-I in altering depression trajectory in adolescent population. This current study aims to compare the effect of digitally delivered, mood enhanced cognitive behavioral therapy for insomnia (M-dCBT-I) and standard digital cognitive behavioral therapy for insomnia (dCBT-I) in improving depressive symptoms in adolescents, and to examine the potential sustained treatment effect in mood outcomes following M-dCBT-I or dCBT-I treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
343

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Apr 2024Dec 2026

First Submitted

Initial submission to the registry

April 2, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

April 20, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

2.1 years

First QC Date

April 2, 2024

Last Update Submit

July 8, 2025

Conditions

Keywords

InsomniaDepressionAdolescent

Outcome Measures

Primary Outcomes (1)

  • Depressive symptoms

    The severity of depressive symptoms as measured by Patient Health Questionnaire 9-item (PHQ-9): locally validated in adolescents and commonly used self-administered questionnaire to assess depressive symptoms and severity. Scores range from 0 to 27, with higher score indicate higher level of depression.

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

Secondary Outcomes (8)

  • Assessor-rated depressive symptomatology

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • Overall severity of depression symptoms

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • Severity of insomnia symptoms

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • Sleep-wake pattern

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • Sleep-related beliefs and cognitions

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • +3 more secondary outcomes

Other Outcomes (3)

  • Major life events and self-perceived stress

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • Chronotype

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

  • Pubertal status

    Baseline, Postintervention (8 weeks), 6-month follow up and 12-month follow up

Study Arms (2)

Standard dCBT-I

ACTIVE COMPARATOR

Treatment content for insomnia was structured and based on the well-established CBT elements for treating insomnia, with developmental adaptation and age-appropriate modification specific for adolescent population. For example, regularity of sleep wake pattern and circadian component will be further emphasized in this age group given the high prevalence of social jetlag resulting from the early school schedule and their natural development delay in circadian rhythm.

Behavioral: Standard dCBT-I

Modified Mood enhanced CBT-I (M-dCBT-I)

EXPERIMENTAL

For mood-enhanced dCBT-I (M-dCBT-I), apart from including core CBT-I component, additional depression specific component including behavioral activation and problem solving. More specifically, cognitive restructuring techniques will cover both unhelpful belief relevant to both insomnia and depression. Psychoeducation will also cover both condition and vignette example will be included in the treatment.

Behavioral: Modified Mood enhanced CBT-I (M-dCBT-I)

Interventions

Standard dCBT-IBEHAVIORAL

This standard digital CBT-I intervention will cover (1) psycho-education about sleep, circadian and sleep hygiene education, (2) stimulus control, (3) sleep restriction, (4) relaxation techniques, (5) structured worry time, (6) cognitive restructuring (targeting sleep-related dysfunctional cognitions), and (7) relapse prevention. In order to have comparable dosage as modified CBT-I, the treatment will be dispersed to 8 modules (8-week) which is still in the range of standard CBT-I duration (usually last for 6-8weeks).

Standard dCBT-I

Additional depression specific components will be added to the standard CBT-I, including behavioral activation and problem solving.

Modified Mood enhanced CBT-I (M-dCBT-I)

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Chinese adolescent aged 12-18 years old
  • presence of insomnia problems as defined by insomnia severity index ≥ 9 (locally validated cut off for detecting clinical insomnia in adolescents)
  • presence of depressive problems as defined by Patient Health Questionnaire-9 (PHQ-9) using cut off of 10 for detecting clinical depression
  • ability to read and understand Chinese
  • possession of smartphone

You may not qualify if:

  • presence of prominent suicidality (suicide plans and suicide attempts) as determined by the Mini-International Neuropsychiatric Interview (MINI)
  • a clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability
  • presence of other sleep disorders that significantly affect sleep continuity or sleep quality (e.g. restless leg symptoms or obstructive sleep apnea syndrome) as determined by validated Diagnostic Interview for Sleep Patterns and Disorders
  • currently receiving psychological treatment for insomnia and/or pharmacological treatment for depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, the Chinese University of Hong Kong

Shatin, New Territories, Hong Kong

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersDepression

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Rachel Ngan Yin Chan, PhD

    Department of Psychiatry, the Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rachel Ngan Yin Chan, PhD

CONTACT

Jucheng Yu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Psychiatry

Study Record Dates

First Submitted

April 2, 2024

First Posted

April 11, 2024

Study Start

April 20, 2024

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 10, 2025

Record last verified: 2025-07

Locations